Looking into woes faced by affected homebuyers

Facebook
X
WhatsApp
Telegram
Email
Tiang (left) is briefed on the project.

LET’S READ SUARA SARAWAK/ NEW SARAWAK TRIBUNE E-PAPER FOR FREE AS ​​EARLY AS 2 AM EVERY DAY. CLICK LINK

SIBU: Homebuyers who have purchased units in a sick housing project will be treated fairly and provided with a solution, says Michael Tiang Ming Tee.

The Deputy Minister for Public Health, Housing, and Local Government assured that he and his team would collaborate with relevant agencies to resolve the issue.

“We will work together to find the best solution to the housing development stagnation through direct negotiations with housing developers and various government departments.

“There are 33 troubled housing projects throughout Sarawak that have affected about 3,000 purchasers,” he said on his Facebook post today.

Tiang stressed that the number of sick projects in Sarawak is not as significant as in other states in the country due to the local ministry’s close monitoring of the matter.

“However, we need to provide justice to the homebuyers,” he stressed.

Tiang (second left) during his site visit.

Meanwhile, according to a news report, Tiang said that the contributing factors to the projects’ delays were financial problems and the challenges faced during the COVID-19 outbreak.

See also  Flood-affected longhouses receive essential supplies

He said that the projects have been delayed by at least one year from their scheduled progress or have had their SPA (Sale and Purchase Agreement) expired.

During his visit to the four troubled housing projects here, he mentioned that some of the houses had already been occupied.

“However, the developer cannot blame the purchasers for staying there illegally, as they have no choice but to move in after paying for years,” he said.

The Pelawan assemblyman said that his task force would have a meeting with each of the housing developers to ensure that they not only complete the project but also offer solutions to the homebuyers.

Download from Apple Store or Play Store.